发明名称 |
A PHARMACEUTICAL COMPOSITION COMPRISING FORM II CRYSTALLINE RITONAVIR AND A PREPARATION THEREOF |
摘要 |
<p>The present invention relates to substantially pure amorphous ritonavir and a process for the preparation thereof. The invention also relates to a process for the praparation of the substantially pure ritonavir crystalline polymorph Form I. <IMAGE></p> |
申请公布号 |
PT2017269(E) |
申请公布日期 |
2011.12.20 |
申请号 |
PT20080007622T |
申请日期 |
1999.07.19 |
申请人 |
ABBOTT LABORATORIES |
发明人 |
JOHN F. BAUER;KETAN PATEL;HARRY O. SPIWEK;SANJAY R. CHEMBURKAR;AZITA SALEKI-GERHARDT |
分类号 |
C07D277/24;A61K31/425;A61K31/426;A61K31/427;A61P31/18;A61P37/04;C07D277/28;C07D277/30;C07D277/36;C07D277/40;C07D277/42;C07D417/12 |
主分类号 |
C07D277/24 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|